ASLAN Pharmaceuticals (ASLN) Competitors $0.60 0.00 (0.00%) As of 07/11/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsOptions ChainSEC FilingsTrendsBuy This Stock ASLN vs. SNOA, MBRX, CMND, GLTO, MTNB, RDHL, DRMA, VIVS, EVOK, and TTNPShould you be buying ASLAN Pharmaceuticals stock or one of its competitors? The main competitors of ASLAN Pharmaceuticals include Sonoma Pharmaceuticals (SNOA), Moleculin Biotech (MBRX), Clearmind Medicine (CMND), Galecto (GLTO), Matinas Biopharma (MTNB), Redhill Biopharma (RDHL), Dermata Therapeutics (DRMA), VivoSim Labs (VIVS), Evoke Pharma (EVOK), and Titan Pharmaceuticals (TTNP). These companies are all part of the "pharmaceutical products" industry. ASLAN Pharmaceuticals vs. Its Competitors Sonoma Pharmaceuticals Moleculin Biotech Clearmind Medicine Galecto Matinas Biopharma Redhill Biopharma Dermata Therapeutics VivoSim Labs Evoke Pharma Titan Pharmaceuticals ASLAN Pharmaceuticals (NASDAQ:ASLN) and Sonoma Pharmaceuticals (NASDAQ:SNOA) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk. Do insiders and institutionals hold more shares of ASLN or SNOA? 58.8% of ASLAN Pharmaceuticals shares are owned by institutional investors. Comparatively, 2.0% of Sonoma Pharmaceuticals shares are owned by institutional investors. 4.7% of ASLAN Pharmaceuticals shares are owned by company insiders. Comparatively, 3.9% of Sonoma Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media favor ASLN or SNOA? In the previous week, Sonoma Pharmaceuticals had 2 more articles in the media than ASLAN Pharmaceuticals. MarketBeat recorded 2 mentions for Sonoma Pharmaceuticals and 0 mentions for ASLAN Pharmaceuticals. Sonoma Pharmaceuticals' average media sentiment score of 0.94 beat ASLAN Pharmaceuticals' score of 0.00 indicating that Sonoma Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment ASLAN Pharmaceuticals Neutral Sonoma Pharmaceuticals Positive Which has stronger valuation & earnings, ASLN or SNOA? Sonoma Pharmaceuticals has higher revenue and earnings than ASLAN Pharmaceuticals. Sonoma Pharmaceuticals is trading at a lower price-to-earnings ratio than ASLAN Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioASLAN Pharmaceuticals$12M0.10-$44.22M-$21.92-0.03Sonoma Pharmaceuticals$14.29M0.41-$3.46M-$3.10-1.16 Is ASLN or SNOA more profitable? ASLAN Pharmaceuticals has a net margin of 0.00% compared to Sonoma Pharmaceuticals' net margin of -24.23%. Sonoma Pharmaceuticals' return on equity of -58.73% beat ASLAN Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets ASLAN PharmaceuticalsN/A -8,454.87% -121.60% Sonoma Pharmaceuticals -24.23%-58.73%-21.05% Which has more volatility & risk, ASLN or SNOA? ASLAN Pharmaceuticals has a beta of 1.4, suggesting that its share price is 40% more volatile than the S&P 500. Comparatively, Sonoma Pharmaceuticals has a beta of 1.33, suggesting that its share price is 33% more volatile than the S&P 500. SummarySonoma Pharmaceuticals beats ASLAN Pharmaceuticals on 8 of the 13 factors compared between the two stocks. Get ASLAN Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ASLN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ASLN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASLN vs. The Competition Export to ExcelMetricASLAN PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.23M$873.29M$5.56B$9.11BDividend YieldN/A4.84%5.07%4.01%P/E Ratio-0.031.1621.2120.54Price / Sales0.10241.37432.0899.78Price / CashN/A17.6937.1257.67Price / Book-0.096.588.045.49Net Income-$44.22M-$23.83M$3.19B$250.45M7 Day PerformanceN/A1.59%3.63%4.79%1 Month PerformanceN/A12.09%4.06%7.68%1 Year Performance-76.19%4.39%30.02%16.43% ASLAN Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASLNASLAN PharmaceuticalsN/A$0.60flatN/AN/A$1.23M$12M-0.0330SNOASonoma Pharmaceuticals0.7371 of 5 stars$3.15+6.1%N/A+917.2%$4.88M$14.29M-1.02180Gap UpMBRXMoleculin Biotech3.0472 of 5 stars$0.39+14.4%$4.00+928.8%-86.1%$4.80MN/A0.0020Positive NewsHigh Trading VolumeCMNDClearmind Medicine0.8981 of 5 stars$0.99-9.8%N/A-41.0%$4.69MN/A-0.90N/AGap DownGLTOGalecto3.2677 of 5 stars$3.24-8.5%$10.00+208.6%-72.6%$4.68MN/A-0.2140MTNBMatinas BiopharmaN/A$0.92+0.3%N/AN/A$4.68MN/A-0.1930RDHLRedhill BiopharmaN/A$2.06+1.5%N/A-99.1%$4.65M$8.04M0.00210DRMADermata Therapeutics2.2393 of 5 stars$0.70+4.7%$3.00+331.7%-72.5%$4.24MN/A-0.048News CoveragePositive NewsGap UpVIVSVivoSim LabsN/A$1.77+12.7%N/AN/A$4.08M$140K-0.1720Positive NewsHigh Trading VolumeEVOKEvoke Pharma0.8245 of 5 stars$2.65-2.6%N/A-12.1%$4.06M$10.25M-0.924News CoverageTTNPTitan Pharmaceuticals0.3354 of 5 stars$4.45+1.1%N/A-9.1%$4.02MN/A-0.9710 Related Companies and Tools Related Companies SNOA Alternatives MBRX Alternatives CMND Alternatives GLTO Alternatives MTNB Alternatives RDHL Alternatives DRMA Alternatives VIVS Alternatives EVOK Alternatives TTNP Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ASLN) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get PaidBank of America believes gold could hit $4,000 an ounce in the next 12 months. That's an 18% jump from toda...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ASLAN Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share ASLAN Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
